Danaher (DHR)
(Delayed Data from NYSE)
$250.07 USD
+2.89 (1.17%)
Updated Nov 5, 2024 04:00 PM ET
After-Market: $249.95 -0.12 (-0.05%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth C Momentum F VGM
Price, Consensus and EPS Surprise
DHR 250.07 +2.89(1.17%)
Will DHR be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for DHR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for DHR
Danaher (DHR) Reliance on International Sales: What Investors Need to Know
Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y
DHR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Week Opens With Markets on a Pullback Mode
Stock Markets Taper on High Valuations, Upcoming Election
Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
Other News for DHR
B&G Foods Reports Q3 2024 Financial Results
B&G Foods (BGS) Receives a Hold from RBC Capital
Closing Bell Movers: Exact Sciences falls 30% after results, guidance cut
B&G Foods Reports Q3 2024 Sales Decline
Barclays Issues a Hold Rating on B&G Foods (BGS)